Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/177558Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ferrer, Ferran | - |
| dc.contributor.author | Pont, Àngels | - |
| dc.contributor.author | Blas, Rodolfo de | - |
| dc.contributor.author | Boladeras, Anna | - |
| dc.contributor.author | Garin, O. | - |
| dc.contributor.author | Ventura, Montse | - |
| dc.contributor.author | Zardoya, Eva | - |
| dc.contributor.author | Delgado, J. | - |
| dc.contributor.author | Condom, E. | - |
| dc.contributor.author | Merino, E. | - |
| dc.contributor.author | Mases, Joel | - |
| dc.contributor.author | Castells-Esteve, Manel | - |
| dc.contributor.author | Guix, Inés | - |
| dc.contributor.author | Suarez, Jose Francisco | - |
| dc.contributor.author | Gonzalez, Javier | - |
| dc.contributor.author | Almendros, Sonia | - |
| dc.contributor.author | Garcia, M. | - |
| dc.contributor.author | Berenguer, Miguel Ángel | - |
| dc.contributor.author | Garcia, N. | - |
| dc.contributor.author | Stefanovic, M. | - |
| dc.contributor.author | Gutierrez, Cristina | - |
| dc.contributor.author | Picon, Cristina | - |
| dc.contributor.author | Ferrer, Montserrat | - |
| dc.contributor.author | Guedea Edo, Ferran | - |
| dc.date.accessioned | 2021-05-25T07:25:16Z | - |
| dc.date.available | 2021-05-25T07:25:16Z | - |
| dc.date.issued | 2019-04-01 | - |
| dc.identifier.issn | 0167-8140 | - |
| dc.identifier.uri | https://hdl.handle.net/2445/177558 | - |
| dc.description.abstract | Purpose or ObjectiveExtracranial stereotactic body radiation therapy (SBRT) allows delivering high doses per fraction with high accuracy to the prostatic gland in a low number of fractions.Dose escalation in normofractionaded radiation prostate cancer trials showed an increased toxicity.In order to evaluate the feasibility and toxicity of a regimen of a single dose hypofractionated prostate stereotactic boost a phase II study was undertaken. Self-reported quality of life (QOL) measures were also obtained in order to better define the possible deleterious effect of treatment. | ca |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | ca |
| dc.publisher | Elsevier BV | ca |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/S0167-8140(19)31959-0 | - |
| dc.relation.ispartof | Radiotherapy and Oncology, 2019, vol. 133, p. S830-S831 | - |
| dc.relation.uri | https://doi.org/10.1016/S0167-8140(19)31959-0 | - |
| dc.rights | cc by-nc-nd (c) Elsevier Ireland Ltd, 2019 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
| dc.subject.classification | Radioteràpia | - |
| dc.subject.classification | Càncer de pròstata | - |
| dc.subject.other | Radiotherapy | - |
| dc.subject.other | Prostate cancer | - |
| dc.title | Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial | ca |
| dc.type | info:eu-repo/semantics/conferenceObject | ca |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.date.updated | 2021-03-10T14:05:31Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca |
| Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PIIS0167814019319590.pdf | 2.28 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
